Medicinova Inc balance sheet

At the end of fiscal 2025, Medicinova Inc had total assets of $45.6m, total liabilities of $4.0m and shareholders' equity of $41.6m. It held $30.8m in cash against $0 of debt: net cash of $30.8m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Medicinova Inc: balance sheet, annual
Fiscal year	2012Dec 2012	2021Dec 2021	2023Dec 2023	2025Dec 2025	LTMJun 2026
Cash and equivalents	4	71	51	31	25
Receivables	—	0	—	0	0
Total current assets	4	72	51	31	26
Goodwill	10	10	10	10	10
Total assets	20	87	66	46	40
Accounts payable	0	0	1	1	1
Deferred revenue (current)	0	—	—	0	0
Total current liabilities	1	3	3	4	3
Total debt	0	0	0	0	0
Total liabilities	5	4	4	4	3
Shareholders' equity	15	84	62	42	37
Net debt (negative = net cash)	−4	−71	−51	−31	−25
Shares outstanding	52m	49m	49m	49m	49m

US$ millions unless shown otherwise. Fiscal quarters.

Medicinova Inc: balance sheet, quarterly
Quarter	2021 Q4Dec 2021	2023 Q3Sept 2023	2023 Q4Dec 2023	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	0	1	—	0	0	0	0	0
Total current assets	72	53	51	35	33	31	28	26
Goodwill	10	10	10	10	10	10	10	10
Total assets	87	68	66	50	48	46	43	40
Accounts payable	0	1	1	1	1	1	1	1
Deferred revenue (current)	—	—	—	—	1	0	0	0
Total current liabilities	3	3	3	3	3	4	3	3
Total liabilities	4	3	4	3	4	4	3	3
Shareholders' equity	84	65	62	47	44	42	39	37
Shares outstanding	49m	49m	49m	49m	49m	49m	49m	49m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: MNOV vs STTK LGVN vs MNOV DARE vs MNOV

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Medicinova Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Medicinova Inc.